Anne Doering

Anne Doering

Director of Finance/CFO at VIVORYON THERAPEUTICS N.V.

Net worth: - $ as of 2026-08-30

Consumer Services
Health Technology
Finance

Profile

Anne Marie Doering currently works at Vivoryon Therapeutics NV, as Chief Financial Officer & Executive Director from 2024.
Ms. Doering also formerly worked at BioNTech SE, as Director-Investor Relations, Merck KGaA, as Director-Group Strategy, Creathor Venture Management GmbH, as Investment Manager, and Franklin Templeton Investment Management Ltd. (Germany), as Portfolio Manager & Research Analyst from 2010 to 2019.
Ms. Doering received her graduate degree from the University of Pennsylvania, graduate degree from Joseph H Lauder Institute of Management & International, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-03-14 0 ( -.--% ) - $ 2026-08-30

Anne Doering active positions

CompaniesPositionStart
VIVORYON THERAPEUTICS N.V. Director of Finance/CFO 2024-02-29

Former positions of Anne Doering

CompaniesPositionEnd
Analyst-Equity 2018-12-31
Private Equity Investor 2010-10-31
MERCK KGAA Corporate Officer/Principal -
BIONTECH SE Investor Relations Contact -
See the detail of Anne Doering's experience

Training of Anne Doering

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Finance

Commercial Services

Health Technology

Finance

Consumer Services

Consumer Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!